The BRCA1/BARD1 ubiquitin ligase and its substrates.
| Autor: | Witus SR; Department of Biochemistry, University of Washington School of Medicine, Seattle, Washington, U.S.A., Stewart MD; Department of Biology, Texas Christian University, Fort Worth, Texas, U.S.A., Klevit RE; Department of Biochemistry, University of Washington School of Medicine, Seattle, Washington, U.S.A. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The Biochemical journal [Biochem J] 2021 Sep 30; Vol. 478 (18), pp. 3467-3483. |
| DOI: | 10.1042/BCJ20200864 |
| Abstrakt: | Mutations in breast cancer type 1 susceptibility protein (BRCA1) and its heterodimeric binding partner BARD1 confer a high risk for the development of breast and ovarian cancers. The sole enzymatic function of the BRCA1/BARD1 complex is as a RING-type E3 ubiquitin (Ub) ligase, leading to the deposition of Ub signals onto a variety of substrate proteins. Distinct types of Ub signals deposited by BRCA1/BARD1 (i.e. degradative vs. non-degradative; mono-Ub vs. poly-Ub chains) on substrate proteins mediate aspects of its function in DNA double-stranded break repair, cell-cycle regulation, and transcriptional regulation. While cancer-predisposing mutations in both subunits lead to the inactivation of BRCA1/BARD1 ligase activity, controversy remains as to whether its Ub ligase activity directly inhibits tumorigenesis. Investigation of BRCA1/BARD1 substrates using rigorous, well-validated mutants and experimental systems will ultimately clarify the role of its ligase activity in cancer and possibly establish prognostic and diagnostic metrics for patients with mutations. In this review, we discuss the Ub ligase function of BRCA1/BARD1, highlighting experimental approaches, mechanistic considerations, and reagents that are useful in the study of substrate ubiquitylation. We also discuss the current understanding of two well-established BRCA1/BARD1 substrates (nucleosomal H2A and estrogen receptor α) and several recently discovered substrates (p50, NF2, Oct1, and LARP7). Lessons from the current body of work should provide a road map to researchers examining novel substrates and biological functions attributed to BRCA1/BARD1 Ub ligase activity. (© 2021 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|